HLA-DQ4 Antibodies

Santa Cruz Biotechnology offers a broad range of HLA-DQ4 monoclonal antibodies for immunology and related research fields. HLA-DQ4 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-DQ4 is a crucial component of the human immune system, playing a significant role in the presentation of antigens to T cells, which is essential for initiating immune responses. Its involvement in autoimmune diseases and transplant rejection highlights the importance of studying HLA-DQ4 in both clinical and research settings. Understanding the function and regulation of HLA-DQ4 can provide insights into disease mechanisms and potential therapeutic targets. Researchers investigating HLA-DQ4 expression patterns can utilize specific conjugates including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced detection and visualization. Current research focuses on understanding how HLA-DQ4 influences immune response regulation and its role in various pathological conditions. Exploring HLA-DQ4's molecular interactions and signaling pathways continues to reveal new aspects of immune system function. Santa Cruz Biotechnology monoclonal antibodies for HLA-DQ4 enable researchers worldwide to advance scientific understanding of immune system regulation and disease mechanisms.